• 154,527+ Medical Conferences
  • 285 Specialties
  • 11,293 Organizers
  • 156,433 Speakers
  • 159 Countries
  • 4,785 Cities
CME Conference Registrations Sold
Home  >  Speakers  >  Gaby L. Danan
Gaby L. Danan

Gaby L. Danan

    MD, PhD
Paris, Ile-de-France    France
Internal Medicine And General Medicine, Hepatology,...More
Pharmacology, Internal Medicine,...More
Spoken at 5 events

Biography :

Gaby L. Danan is board qualified in Hepatology and Internal Medicine. He conducted experimental and clinical studies dealing with drug hepatotoxicity and drug-drug interactions. He joined the pharmaceutical industry in 1984 and was EU Qualified Person for Pharmacovigilance in Sanofi S.A. before his retirement in 2010. Together with Dr Christian Benichou he published in 1993 a causality assessment method for suspected Drug-Induced Liver Injury known as RUCAM.

From 1992 to 2009, he was a member of several CIOMS groups and ICH Expert Working Groups especially on Clinical Safety as EFPIA topic leader of E2B. He authored numerous papers and book chapters on definitions and methodology in Pharmacovigilance.

*** * *** ** ***
For speaker's contact information - Contact us


Internal Medicine and General Medicine, Hepatology, Clinical Pharmacology

Interested Topics

Pharmacology, Internal medicine, Hepatology, Pharmaceutical Industry, Healthcare, GCP, Clinical Research, Public Health, FDA, Pharmacovigilance, Drug Development

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Send Message